#oncology #womenshealth #CorceptTherapeutics #relacorilant #ovariancancer #cancerinwomen #cortisolmodulatingmedications #platinumresistantovariancancer #ROSELLAtrial #gynaecologicalcancerresearch #glucocorticoidreceptor #cortisolmodulatingtreatments
zurl.co/JWBM3
zurl.co/JWBM3
Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer - PharmaTimes
Ovarian cancer is the fifth leading cause of deaths from cancer in women
pharmatimes.com
January 26, 2026 at 12:37 PM